Relevance of post-stroke circulating BDNF levels as a prognostic biomarker of stroke outcome. Impact of rt-PA treatment

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Rodier, Marion ^a,b,d   Quirié, Aurore ^a,b,c   Prigent Tessier, Anne ^a,b   Béjot, Yannick ^d,e   Jacquin, Agnès ^d,e   Mossiat, Claude ^a,b   Marie, Christine ^a,b   Garnier, Philippe ^a,b,c  

^a Université de Bourgogne   (France)

^b UNIVERSITÉ BOURGOGNE FRANCHE COMTÉ   (France)

^c IUT   (France)

^d DIJON UNIVERSITY HOSPITAL   (France)

^e Centre D'Epidémiologie des Populations   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; BRAIN DERIVED NEUROTROPHIC FACTOR; PLASMIN; TISSUE PLASMINOGEN ACTIVATOR; BIOLOGICAL MARKER; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN; FIBRINOLYTIC AGENT;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NONHUMAN; OUTCOME ASSESSMENT; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RAT; TREATMENT OUTCOME; ANIMAL; BLOOD; MIDDLE AGED; PERFUSION; STROKE;

AGED; ANIMALS; BIOMARKERS; BRAIN ISCHEMIA; BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PERFUSION; PROGNOSIS; RATS; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84949032784     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0140668     Document Type: Article

References (46)

1. Yepes M, Roussel BD, Ali C, Vivien D (2009) Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic. Trends Neurosci 32: 48-55. doi: 10.1016/j.tins.2008.09.006 PMID: 18963068
2. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, et al. (1994) Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368: 419-424. PMID: 8133887
3. Huang YY, Bach ME, Lipp HP, Zhuo M, Wolfer DP, Hawkins RD, et al. (1996) Mice lacking the gene encoding tissue-type plasminogen activator show a selective interference with late-phase long-term potentiation in both Schaffer collateral and mossy fiber pathways. Proc Natl Acad Sci U S A 93: 8699-8704. PMID: 8710934
4. Baranes D, Lederfein D, Huang YY, Chen M, Bailey CH, Kandel ER (1998) Tissue plasminogen activator contributes to the late phase of LTP and to synaptic growth in the hippocampal mossy fiber pathway. Neuron 21: 813-825. PMID: 9808467
5. Lemarchant S, Docagne F, Emery E, Vivien D, Ali C, Rubio M (2012) tPA in the injured central nervous system: different scenarios starring the same actor? Neuropharmacology 62: 749-756. doi: 10.1016/j. neuropharm.2011.10.020 PMID: 22079561
6. Benchenane K, Berezowski V, Ali C, Fernandez-Monreal M, Lopez-Atalaya JP, Brillault J, et al. (2005) Tissue-type plasminogen activator crosses the intact blood-brain barrier by low-density lipoprotein receptor-related protein-mediated transcytosis. Circulation 111: 2241-2249. PMID: 15851587
7. Vivien D, Gauberti M, Montagne A, Defer G, Touze E (2011) Impact of tissue plasminogen activator on the neurovascular unit: from clinical data to experimental evidence. J Cereb Blood Flow Metab 31: 2119-2134. doi: 10.1038/jcbfm.2011.127 PMID: 21878948
8. Cowansage KK, LeDoux JE, Monfils MH (2010) Brain-derived neurotrophic factor: a dynamic gatekeeper of neural plasticity. Curr Mol Pharmacol 3: 12-29. PMID: 20030625
9. Mattson MP (2008) Glutamate and neurotrophic factors in neuronal plasticity and disease. Ann N Y Acad Sci 1144: 97-112. doi: 10.1196/annals.1418.005 PMID: 19076369
10. Lipsky RH, Marini AM (2007) Brain-derived neurotrophic factor in neuronal survival and behaviorrelated plasticity. Ann N Y Acad Sci 1122: 130-143. PMID: 18077569
11. Pang PT, Teng HK, Zaitsev E, Woo NT, Sakata K, Zhen S, et al. (2004) Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 306: 487-491. PMID: 15486301
12. Nagappan G, Zaitsev E, Senatorov VV Jr., Yang J, Hempstead BL, Lu B (2009) Control of extracellular cleavage of ProBDNF by high frequency neuronal activity. Proc Natl Acad Sci U S A 106: 1267-1272. doi: 10.1073/pnas.0807322106 PMID: 19147841
13. Rodier M, Prigent-Tessier A, Bejot Y, Jacquin A, Mossiat C, Marie C, et al. (2014) Exogenous t-PA Administration Increases Hippocampal Mature BDNF Levels. Plasmin-or NMDA-Dependent Mechanism? PLoS One 9: e92416. doi: 10.1371/journal.pone.0092416 PMID: 24670989
14. Rosenfeld RD, Zeni L, Haniu M, Talvenheimo J, Radka SF, Bennett L, et al. (1995) Purification and identification of brain-derived neurotrophic factor from human serum. Protein Expr Purif 6: 465-471. PMID: 8527932
15. Munkholm K, Pedersen BK, Kessing LV, VinbergM (2014) Elevated levels of plasma brain derived neurotrophic factor in rapid cycling bipolar disorder patients. Psychoneuroendocrinology 47: 199-211. doi: 10.1016/j.psyneuen.2014.05.011 PMID: 25001969
16. Dwivedi Y (2013) Involvement of brain-derived neurotrophic factor in late-life depression. Am J Geriatr Psychiatry 21: 433-449. doi: 10.1016/j.jagp.2012.10.026 PMID: 23570887
17. Bejot Y, Mossiat C, Giroud M, Prigent-Tessier A, Marie C (2011) Circulating and brain BDNF levels in stroke rats. Relevance to clinical studies. PLoS One 6: e29405. doi: 10.1371/journal.pone.0029405 PMID: 22195050
18. van Donkelaar EL, van den Hove DL, Blokland A, Steinbusch HW, Prickaerts J (2009) Stress-mediated decreases in brain-derived neurotrophic factor as potential confounding factor for acute tryptophan depletion-induced neurochemical effects. Eur Neuropsychopharmacol 19: 812-821. doi: 10.1016/j. euroneuro.2009.06.012 PMID: 19640687
19. Millerot-Serrurot E, Chausset A, Mossiat C, Prigent-Tessier A, Bertrand N, Garnier P, et al. (2007) Effect of early decrease in the lesion size on late brain tissue loss, synaptophysin expression and functionality after a focal brain lesion in rats. Neurochem Int 50: 328-335. PMID: 17027119
20. Madinier A, Bertrand N, Rodier M, Quirie A, Mossiat C, Prigent-Tessier A, et al. (2013) Ipsilateral versus contralateral spontaneous post-stroke neuroplastic changes: involvement of BDNF? Neuroscience 231: 169-181. doi: 10.1016/j.neuroscience.2012.11.054 PMID: 23219910
21. Quirie A, Hervieu M, Garnier P, Demougeot C, Mossiat C, Bertrand N, et al. (2012) Comparative effect of treadmill exercise on mature BDNF production in control versus stroke rats. PLoS One 7: e44218. doi: 10.1371/journal.pone.0044218 PMID: 22962604
22. Di Lazzaro V, Profice P, Pilato F, Dileone M, Florio L, Tonali PA, et al. (2007) BDNF plasma levels in acute stroke. Neurosci Lett 422: 128-130. PMID: 17590513
23. Yang L, Zhang Z, Sun D, Xu Z, Yuan Y, Zhang X, et al. (2011) Low serum BDNF may indicate the development of PSD in patients with acute ischemic stroke. Int J Geriatr Psychiatry 26: 495-502. doi:10. 1002/gps.2552 PMID: 20845405
24. Zhou Z, Lu T, Xu G, Yue X, Zhu W, Ma M, et al. (2011) Decreased serum brain-derived neurotrophic factor (BDNF) is associated with post-stroke depression but not with BDNF gene Val66Met polymorphism. Clin Chem Lab Med 49: 185-189. doi: 10.1515/CCLM.2011.039 PMID: 21143020
25. Autry AE, Monteggia LM (2012) Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev 64: 238-258. doi: 10.1124/pr.111.005108 PMID: 22407616
26. Yoshida T, Ishikawa M, Niitsu T, Nakazato M, Watanabe H, Shiraishi T, et al. (2012) Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder. PLoS One 7: e42676. doi: 10.1371/journal.pone.0042676 PMID: 22880079
27. Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ (1998) Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 37: 1553-1561. PMID: 9886678
28. Begliuomini S, Casarosa E, Pluchino N, Lenzi E, Centofanti M, Freschi L, et al. (2007) Influence of endogenous and exogenous sex hormones on plasma brain-derived neurotrophic factor. Hum Reprod 22: 995-1002. PMID: 17251358
29. Fujimura H, Altar CA, Chen R, Nakamura T, Nakahashi T, Kambayashi J, et al. (2002) Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb Haemost 87: 728-734. PMID: 12008958
30. Lommatzsch M, Zingler D, Schuhbaeck K, Schloetcke K, Zingler C, Schuff-Werner P, et al. (2005) The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging 26: 115-123. PMID: 15585351
31. Bus BA, Molendijk ML, Penninx BJ, Buitelaar JK, Kenis G, Prickaerts J, et al. (2011) Determinants of serum brain-derived neurotrophic factor. Psychoneuroendocrinology 36: 228-239. doi: 10.1016/j. psyneuen.2010.07.013 PMID: 20702043
32. Trajkovska V, Marcussen AB, Vinberg M, Hartvig P, Aznar S, Knudsen GM (2007) Measurements of brain-derived neurotrophic factor: methodological aspects and demographical data. Brain Res Bull 73: 143-149. PMID: 17499648
33. Golden E, Emiliano A, Maudsley S, Windham BG, Carlson OD, Egan JM, et al. (2010) Circulating brainderived neurotrophic factor and indices of metabolic and cardiovascular health: data from the Baltimore Longitudinal Study of Aging. PLoS One 5: e10099. doi: 10.1371/journal.pone.0010099 PMID: 20404913
34. Krabbe KS, Nielsen AR, Krogh-Madsen R, Plomgaard P, Rasmussen P, Erikstrup C, et al. (2007) Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia 50: 431-438. PMID: 17151862
35. Ghiadoni L, Taddei S, Virdis A (2012) Hypertension and endothelial dysfunction: therapeutic approach. Curr Vasc Pharmacol 10: 42-60. PMID: 22112351
36. Chaldakov GN, Fiore M, Stankulov IS, Manni L, Hristova MG, Antonelli A, et al. (2004) Neurotrophin presence in human coronary atherosclerosis and metabolic syndrome: a role for NGF and BDNF in cardiovascular disease? Prog Brain Res 146: 279-289. PMID: 14699970
37. Lorgis L, Amoureux S, de Maistre E, Sicard P, Bejot Y, Zeller M, et al. (2010) Serum brain-derived neurotrophic factor and platelet activation evaluated by soluble P-selectin and soluble CD-40-ligand in patients with acute myocardial infarction. Fundam Clin Pharmacol 24: 525-530. doi: 10.1111/j.1472-8206.2009.00790.x PMID: 19909348
38. Manni L, Nikolova V, Vyagova D, Chaldakov GN, Aloe L (2005) Reduced plasma levels of NGF and BDNF in patients with acute coronary syndromes. Int J Cardiol 102: 169-171. PMID: 15939120
39. Jiang H, Liu Y, Zhang Y, Chen ZY (2011) Association of plasma brain-derived neurotrophic factor and cardiovascular risk factors and prognosis in angina pectoris. Biochem Biophys Res Commun 415: 99-103. doi: 10.1016/j.bbrc.2011.10.020 PMID: 22020095
40. Pikula A, Beiser AS, Chen TC, Preis SR, Vorgias D, DeCarli C, et al. (2013) Serum brain-derived neurotrophic factor and vascular endothelial growth factor levels are associated with risk of stroke and vascular brain injury: Framingham Study. Stroke 44: 2768-2775. doi: 10.1161/STROKEAHA.113.001447 PMID: 23929745
41. Nakahashi T, Fujimura H, Altar CA, Li J, Kambayashi J, Tandon NN, et al. (2000) Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Lett 470: 113-117. PMID: 10734218
42. Bejot Y, Prigent-Tessier A, Cachia C, Giroud M, Mossiat C, Bertrand N, et al. (2011) Time-dependent contribution of non neuronal cells to BDNF production after ischemic stroke in rats. Neurochem Int 58: 102-111. doi: 10.1016/j.neuint.2010.10.019 PMID: 21074587
43. Rasmussen P, Brassard P, Adser H, Pedersen MV, Leick L, Hart E, et al. (2009) Evidence for a release of brain-derived neurotrophic factor from the brain during exercise. Exp Physiol 94: 1062-1069. doi: 10.1113/expphysiol.2009.048512 PMID: 19666694
44. Prigent-Tessier A, Quirie A, Maguin-Gate K, Szostak J, Mossiat C, Nappey M, et al. (2013) Physical training and hypertension have opposite effects on endothelial brain-derived neurotrophic factor expression. Cardiovasc Res 100: 374-382. doi: 10.1093/cvr/cvt219 PMID: 24092446
45. Navaratna D, Guo SZ, Hayakawa K, Wang X, Gerhardinger C, Lo EH (2011) Decreased cerebrovascular brain-derived neurotrophic factor-mediated neuroprotection in the diabetic brain. Diabetes 60: 1789-1796. doi: 10.2337/db10-1371 PMID: 21562076
46. Kaess BM, Preis SR, Lieb W, Beiser AS, Yang Q, Chen TC, et al. (2015) Circulating brain-derived neurotrophic factor concentrations and the risk of cardiovascular disease in the community. J Am Heart Assoc 4: e001544. doi: 10.1161/JAHA.114.001544 PMID: 25762803